MRT Pharma
Building Infrastructure for the Future of Precision Oncology
MRT Pharma is developing next-generation infrastructure for the movement of radiopharmaceuticals between production facilities, imaging centers, and cancer treatment environments.
Contact UsThe Challenge
Logistics Systems Built for Yesterday's Scale
As nuclear medicine and radiopharmaceutical therapies grow, hospitals and healthcare systems are expanding across larger campuses and distributed care environments. Existing logistics systems were not designed for the future scale of precision oncology.
Our Vision
New Infrastructure for a New Era of Medicine
We believe healthcare systems will require new infrastructure to support the safe, efficient, and scalable movement of radiopharmaceutical materials across increasingly complex treatment environments.
Technology
Next-Generation Radiopharmaceutical Logistics Infrastructure
MRT Pharma is developing next-generation infrastructure designed specifically for radiopharmaceutical logistics and advanced healthcare environments — engineered for the scale and precision demands of modern oncology.
Patent Portfolio
Intellectual Property Under Development
Multiple U.S. patent applications filed.
Additional intellectual property under development.
Leadership
Leadership Team
Paul Onaodowan
Founder & CEO
Engineer, data analyst, entrepreneur and inventor focused on healthcare infrastructure innovation and radiopharmaceutical logistics.
Dr. Ejiro Akpovwovwo
Co-Founder
Healthcare professional with radiopharmacy and nuclear medicine experience supporting the development of MRT Pharma's precision oncology infrastructure vision.
Contact
Get in Touch
Paul Onaodowan
Founder & CEO, MRT Pharma